ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,552Medicare Part D Prescriptions Filled, Including Refills

Rank: 256 out of 2456

$343K Total Retail Price of All Prescriptions

Rank: 489 out of 2456

472 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 472 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 472 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 7,644 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 708 636 1 1
SIMVASTATIN 572 511 2 2
ATENOLOL 521 491 3 6
HYDROCHLOROTHIAZIDE 356 319 4 7
LEVOTHYROXINE SODIUM 343 305 5 4
METOPROLOL TARTRATE 288 279 6 10
ATORVASTATIN CALCIUM 287 268 7 12
FUROSEMIDE 225 222 8 8
WARFARIN SODIUM 167 160 9 9
AMLODIPINE BESYLATE 165 165 10 5
ALENDRONATE SODIUM 152 133 11 19
METOPROLOL SUCCINATE 124 113 12 13
OXYCODONE-ACETAMINOPHEN 124 98 S2 12 35
SERTRALINE HCL 116 75 14 21
ZOLPIDEM TARTRATE 114 109 15 28
METFORMIN HCL 111 85 16 11
GABAPENTIN 104 97 17 16
DIOVAN 103 102 18 26
LORAZEPAM 102 92 19 67
OMEPRAZOLE 98 59 20 3
GLIPIZIDE 94 82 21 46
HYDROCODONE-ACETAMINOPHEN 91 75 S3 22 20
ADVAIR DISKUS 88 86 23 36
PRAVASTATIN SODIUM 83 76 24 15
NIFEDIAC CC 77 72 25 175
FLUTICASONE PROPIONATE 70 69 26 30
NIFEDIPINE ER 68 59 27 61
CITALOPRAM HBR 68 67 27 14
PROAIR HFA 66 50 29 22
PREDNISONE 65 65 30 39
DEXILANT 60 46 31 114
DIGOXIN 60 60 31 49
ALLOPURINOL 57 48 33 27
LOVASTATIN 55 41 34 34
INSULIN SYRINGE 51 43 35 72
AMITRIPTYLINE HCL 51 51 R 35 83
VENTOLIN HFA 51 27 35 210
PAROXETINE HCL 50 38 38 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.